1. Home
  2. LIMNW vs PLL Comparison

LIMNW vs PLL Comparison

Compare LIMNW & PLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIMNW
  • PLL
  • Stock Information
  • Founded
  • LIMNW N/A
  • PLL 2016
  • Country
  • LIMNW United States
  • PLL United States
  • Employees
  • LIMNW N/A
  • PLL N/A
  • Industry
  • LIMNW
  • PLL Other Metals and Minerals
  • Sector
  • LIMNW
  • PLL Basic Materials
  • Exchange
  • LIMNW Nasdaq
  • PLL Nasdaq
  • Market Cap
  • LIMNW N/A
  • PLL N/A
  • IPO Year
  • LIMNW N/A
  • PLL 2017
  • Fundamental
  • Price
  • LIMNW $0.09
  • PLL $6.01
  • Analyst Decision
  • LIMNW
  • PLL Hold
  • Analyst Count
  • LIMNW 0
  • PLL 6
  • Target Price
  • LIMNW N/A
  • PLL $11.92
  • AVG Volume (30 Days)
  • LIMNW N/A
  • PLL 189.4K
  • Earning Date
  • LIMNW N/A
  • PLL 05-07-2025
  • Dividend Yield
  • LIMNW N/A
  • PLL N/A
  • EPS Growth
  • LIMNW N/A
  • PLL N/A
  • EPS
  • LIMNW N/A
  • PLL N/A
  • Revenue
  • LIMNW N/A
  • PLL $106,472,000.00
  • Revenue This Year
  • LIMNW N/A
  • PLL $0.39
  • Revenue Next Year
  • LIMNW N/A
  • PLL $31.17
  • P/E Ratio
  • LIMNW N/A
  • PLL N/A
  • Revenue Growth
  • LIMNW N/A
  • PLL 100.07
  • 52 Week Low
  • LIMNW N/A
  • PLL $5.15
  • 52 Week High
  • LIMNW N/A
  • PLL $15.44
  • Technical
  • Relative Strength Index (RSI)
  • LIMNW N/A
  • PLL 35.65
  • Support Level
  • LIMNW N/A
  • PLL $6.20
  • Resistance Level
  • LIMNW N/A
  • PLL $6.60
  • Average True Range (ATR)
  • LIMNW 0.00
  • PLL 0.29
  • MACD
  • LIMNW 0.00
  • PLL -0.07
  • Stochastic Oscillator
  • LIMNW 0.00
  • PLL 0.00

About LIMNW Liminatus Pharma Inc. Warrants

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.

Share on Social Networks: